Press release
5G Networks' Performance To Decide The Growth Parameters Of The Umbilical Cord Blood Banking Market
According to a new market report published by Persistence Market Research "Global Market Study on UCB Banking - Asia-Pacific to Witness Highest Growth by 2020" the global UCB banking market is estimated at USD 13,515.8 million in 2014 and is expected to grow at a CAGR of 6.1% from 2014 to 2020, to reach an estimated value of USD 19,335.6 million in 2020.The UCB banking market is witnessing a significant growth due to the increasing prevalence of chronic diseases coupled with regenerative medicines. In addition, initiatives by various government associations have increased the importance of UCB by rising awareness about potential applications of cord blood are also supporting in the growth of the global UCB banking market.
Planning Forward? Access Sample Of Umbilical Cord Blood Banking Market Report! https://www.persistencemarketresearch.com/samples/3043
Some of the major players operating in the UCB banking market:
Cord Blood Registry Systems, Inc.
Cordlife Group Limited.
Cord Blood America, Inc.
NeoStem Inc.
Cryo-Cell International, Inc.
ViaCord.
Esperite NV.
Smart Cells International Ltd.
China Cord Blood Corporation.
How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Umbilical Cord Blood Banking Market? https://www.persistencemarketresearch.com/methodology/3043
However, strict license and accreditation procedures and high cord blood banking fee in private banks hampers the growth of global UCB banking market. As a result, the global UCB banking market is expected to grow a CAGR of 6.1% during 2014-2020.
North America has the largest market for UCB banking. Increasing prevalence of chronic diseases is key driver of UCB banking market in the region. In addition, various government associations have also led to the importance of cord blood donation and services for its future use in North America.
Similarly, the European UCB banking market is mainly driven by the increasing prevalence of diseases. In addition, increased awareness about therapeutic applications of cord blood and rising number of live births are also contributing in the growth of the UCB market in the region.
Planning To Introduce An Offbeat Product/Technology In The Umbilical Cord Blood Banking Market? Go To "Purchase Now" To Have Our Umbilical Cord Blood Banking Market Report! https://www.persistencemarketresearch.com/checkout/3043
In Asia-Pacific, UCB banking market is growing due to rising aging population and increasing prevalence of chronic diseases. In addition, several government associations and increasing number of live births are also increasing the demand of cord blood banking services in the region.
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 5G Networks' Performance To Decide The Growth Parameters Of The Umbilical Cord Blood Banking Market here
News-ID: 2709797 • Views: …
More Releases from Persistence Market Research

Fruit Ingredients Market to Reach US$ 111.3 Bn by 2032, Driven by Rising Health …
Overview of the Global Fruit Ingredients Market
The global fruit ingredients market is witnessing significant growth, driven by rising consumer demand for natural, clean-label, and nutrient-rich food products. In 2025, the market is likely to be valued at US$ 75.0 billion and is expected to reach US$ 111.3 billion by 2032, registering a robust CAGR of 5.8% during the forecast period. Fruit ingredients, which include fruit concentrates, purees, powders, and extracts,…

Vegan Dessert Market to Reach US$ 11.9 Bn by 2032, Driven by Rising Health & Pla …
Overview of the Market
The global vegan dessert market is poised for significant expansion, with an estimated valuation of US$ 5.2 billion in 2025, projected to reach US$ 11.9 billion by 2032. This robust growth reflects a compound annual growth rate (CAGR) of 11.7% during the forecast period from 2025 to 2032. Increasing consumer awareness about health, environmental sustainability, and ethical food consumption is driving the widespread adoption of vegan dessert…

Instant Beverage Premix Market to Reach US$148.3 Bn by 2032 Driven by Convenienc …
Overview of the Global Instant Beverage Premix Market
The global instant beverage premix market has witnessed remarkable growth over the past decade, driven by evolving consumer lifestyles and increasing demand for convenient, ready-to-consume beverages. Instant beverage premixes, encompassing products such as instant coffee, tea, flavored drinks, protein powders, and nutritional supplements, cater to busy consumers seeking quick preparation without compromising on taste or nutritional value. These premixes have gained popularity across…

Dermacosmetics Market to Reach US$ 87.3 Bn by 2032 at 7.4% CAGR: Persistence Mar …
The global dermacosmetics market, estimated at US$ 53 billion in 2025, is forecasted to witness a steady upward trajectory, expanding at a Compound Annual Growth Rate (CAGR) of 7.4% to reach US$ 87.3 billion by 2032. This surge is driven by a confluence of factors ranging from increasing consumer awareness and the rising incidence of skin conditions to a growing preference for advanced, dermatologist-backed skincare solutions. Dermacosmetics, a category that…
More Releases for UCB
Epilepsy Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveI …
The Key Epilepsy Companies in the market include - Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical, Angelini Pharma/Ono Pharmaceutical, Novartis, Xenon Pharmaceuticals, Takeda, Ovid Therapeutics, Biohaven Pharmaceuticals/Knopp Biosciences, and others.
DelveInsight's "Epilepsy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well as the Epilepsy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom…
Epilepsy Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | …
DelveInsight's "Epilepsy Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well as the Epilepsy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Epilepsy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Epilepsy Market Forecast
https://www.delveinsight.com/sample-request/epilepsy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Epilepsy…
Fibromyalgia Market to Exhibit Rapid Growth Rate During the Forecast Period (202 …
DelveInsight's "Fibromyalgia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as the Fibromyalgia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Fibromyalgia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Fibromyalgia Market Forecast
https://www.delveinsight.com/sample-request/fibromyalgia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Fibromyalgia…
Anticonvulsant Market - Functional Survey 2025 | GlaxoSmithKline Inc., UCB Group
Anticonvulsant Market for Fibromyalgia: Snapshot
Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons…
Epilepsy Drugs Market 2017- UCB, EISAI, Pfizer
Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021.
Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing…
Global Stem Cell UCB Market Research Report 2016
Global Stem Cell UCB Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020.
The market intelligence publication delves into the condition of the global Stem Cell UCB market. An in-depth examination of the existing market state, past progress, and forthcoming prospects of the global Stem Cell UCB market has been presented in the research report. The research publication also reports…